EE200000790A - Geeniteraapia meetod - Google Patents

Geeniteraapia meetod

Info

Publication number
EE200000790A
EE200000790A EEP200000790A EEP200000790A EE200000790A EE 200000790 A EE200000790 A EE 200000790A EE P200000790 A EEP200000790 A EE P200000790A EE P200000790 A EEP200000790 A EE P200000790A EE 200000790 A EE200000790 A EE 200000790A
Authority
EE
Estonia
Prior art keywords
gene therapy
therapy method
gene
therapy
Prior art date
Application number
EEP200000790A
Other languages
English (en)
Estonian (et)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Schwachtgen Jean-Luc
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811836.7A external-priority patent/GB9811836D0/en
Priority claimed from GBGB9815035.2A external-priority patent/GB9815035D0/en
Priority claimed from GBGB9819846.8A external-priority patent/GB9819846D0/en
Priority claimed from GBGB9828578.6A external-priority patent/GB9828578D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000790A publication Critical patent/EE200000790A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP200000790A 1998-06-02 1999-06-02 Geeniteraapia meetod EE200000790A (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9811836.7A GB9811836D0 (en) 1998-06-02 1998-06-02 Gene therapy method
GBGB9815035.2A GB9815035D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819846.8A GB9819846D0 (en) 1998-09-12 1998-09-12 Gene therapy method
GBGB9828578.6A GB9828578D0 (en) 1998-12-23 1998-12-23 Regulation
PCT/GB1999/001722 WO1999062561A2 (en) 1998-06-02 1999-06-02 Gene therapy method

Publications (1)

Publication Number Publication Date
EE200000790A true EE200000790A (et) 2002-04-15

Family

ID=27451790

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000790A EE200000790A (et) 1998-06-02 1999-06-02 Geeniteraapia meetod

Country Status (28)

Country Link
US (1) US6689758B1 (is)
EP (2) EP1083934B1 (is)
JP (1) JP2002516676A (is)
KR (1) KR20010043968A (is)
CN (1) CN1311822A (is)
AP (1) AP2000001999A0 (is)
AT (1) ATE246518T1 (is)
AU (1) AU770497B2 (is)
BR (1) BR9910877A (is)
CA (1) CA2334171A1 (is)
DE (1) DE69910202T2 (is)
DK (1) DK1083934T3 (is)
EA (1) EA200001124A1 (is)
EE (1) EE200000790A (is)
ES (1) ES2205830T3 (is)
HR (1) HRP20000832A2 (is)
HU (1) HUP0103252A3 (is)
ID (1) ID27483A (is)
IL (1) IL139936A0 (is)
IS (1) IS5742A (is)
NO (1) NO20006047L (is)
NZ (1) NZ508505A (is)
PL (1) PL345207A1 (is)
PT (1) PT1083934E (is)
SK (1) SK18322000A3 (is)
TR (2) TR200102985T2 (is)
WO (1) WO1999062561A2 (is)
YU (1) YU75600A (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
WO2003060516A1 (en) * 2002-01-10 2003-07-24 Takeda Chemical Industries, Ltd. Screening method
WO2004060476A2 (en) * 2002-12-31 2004-07-22 The Johns Hopkins University Wound healing method and kits
WO2005021045A1 (ja) * 2003-08-29 2005-03-10 Anges Mg, Inc. 針無注射器を用いた皮膚疾患の遺伝子治療
DE10342071B4 (de) * 2003-09-10 2006-01-19 Fleischmann, Wilhelm, Dr.med. Vorrichtung und Verfahren zur Applikation von Wïrkstoffen an eine Wundoberfläche
KR100647490B1 (ko) 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
JP5646320B2 (ja) 2007-05-11 2014-12-24 アダイニクス， インコーポレイテッド 遺伝子発現と疼痛
FR2920158B1 (fr) * 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques
FR2924128A1 (fr) * 2007-11-26 2009-05-29 Galderma Res & Dev Modulateurs de egr1 dans le traitement de l'alopecie
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
CN102552938A (zh) * 2012-03-22 2012-07-11 南京大学 Egr-1拮抗剂在制备治疗Ⅱ型糖尿病的药物中的用途
RU2668136C2 (ru) 2012-05-10 2018-09-26 Эйдинкс, Инк. Композиции для доставки активных ингредиентов
CN106661578B (zh) 2014-08-15 2020-08-04 埃迪恩克斯股份有限公司 用于疼痛治疗的寡核苷酸诱饵
KR101721228B1 (ko) * 2015-04-03 2017-03-30 사회복지법인 삼성생명공익재단 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5763209A (en) * 1988-09-26 1998-06-09 Arch Development Corporation Methods and materials relating to the functional domains of DNA binding proteins
AUPN855496A0 (en) * 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells

Also Published As

Publication number Publication date
NO20006047L (no) 2001-02-01
AU770497B2 (en) 2004-02-26
IS5742A (is) 2000-11-28
WO1999062561A2 (en) 1999-12-09
PL345207A1 (en) 2001-12-03
JP2002516676A (ja) 2002-06-11
AU4156099A (en) 1999-12-20
EA200001124A1 (ru) 2001-08-27
HRP20000832A2 (en) 2001-04-30
HUP0103252A2 (hu) 2001-12-28
KR20010043968A (ko) 2001-05-25
US6689758B1 (en) 2004-02-10
PT1083934E (pt) 2003-12-31
SK18322000A3 (sk) 2001-11-06
HK1034465A1 (en) 2001-10-26
ID27483A (id) 2001-04-12
YU75600A (sh) 2004-03-12
EP1281763A3 (en) 2003-07-09
NO20006047D0 (no) 2000-11-29
TR200102985T2 (tr) 2002-06-21
IL139936A0 (en) 2002-02-10
AP2000001999A0 (en) 2000-12-31
EP1083934A2 (en) 2001-03-21
NZ508505A (en) 2003-04-29
BR9910877A (pt) 2002-01-22
HUP0103252A3 (en) 2003-09-29
ES2205830T3 (es) 2004-05-01
CA2334171A1 (en) 1999-12-09
TR200100348T2 (tr) 2001-07-23
ATE246518T1 (de) 2003-08-15
DE69910202T2 (de) 2004-06-17
WO1999062561A3 (en) 2000-08-03
EP1281763A2 (en) 2003-02-05
DE69910202D1 (de) 2003-09-11
CN1311822A (zh) 2001-09-05
DK1083934T3 (da) 2003-12-01
EP1083934B1 (en) 2003-08-06

Similar Documents

Publication Publication Date Title
IS8368A (is) Ný aðferð
DE69840172D1 (de) Rna exportelement
FI20000863L (fi) Uusi hoitomenetelmä
FI971620A7 (fi) Autentikointimenetelmä
ID27841A (id) Turunan-turunan biaril terapeutik
DE69916691D1 (de) Herzschrittmacher
DE69830295D1 (de) Steuerungsverfahren
DE69906861D1 (de) Steuermethode
DE69815975D1 (de) Steuerungsverfahren
DK1083934T3 (da) Genterapifremgangsmåder
IS5106A (is) Ný aðferð
NO20006531D0 (no) Kontrollmetode
DE69816734D1 (de) Steuerungsverfahren
DK0967286T3 (da) Leucinaminopeptodase-gen
DE50005753D1 (de) Montageverfahren
DE69903035D1 (de) Erwärmungsverfahren
DE19883020T1 (de) Entladungsoberflächen-Behandlungsverfahren
GB9819846D0 (en) Gene therapy method
GB9814989D0 (en) Gene therapy method
GB9811836D0 (en) Gene therapy method
GB9819826D0 (en) Gene therapy method
GB9815035D0 (en) Gene therapy method
SE9802791D0 (sv) Behandlingsmetod
ID26641A (id) Metoda pengobatan
SE9803069D0 (sv) New gene